Ovid Therapeutics

+$0.08 (+2.31%) As of 6:10 PM UTC today

Why Robinhood?

You can buy or sell OVID and other stocks, options, and ETFs commission-free!

About OVID

Ovid Therapeutics Inc. Common Stock, also called Ovid Therapeutics, is a biopharmaceutical company, which engages in the development of medicines for patients and families living with rare neurological disorders.

CEO

Jeremy Max Levin

Employees

Headquarters

New York, New York

Founded

2014

OVID Key Statistics

Market Cap

248.51M

Price-Earnings Ratio

—

Dividend Yield

—

Average Volume

636.31K

High Today

$3.66

Low Today

$3.32

Open Price

$3.39

Volume

419.00K

52 Week High

$9.40

52 Week Low

$2.25

Analyst Ratings

43%

of 7 ratings

Buy

42.9%

Hold

57.1%

Sell

OVID Earnings

-$0.43

-$0.29

-$0.14

$0.00

Q3 FY19

Q4 FY19

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Q1 FY21

Estimated

— per share

Actual

Expected May 25, Pre-Market